Improve Focus With Behavioral Tools & Medication for ADHD | Dr. John Kruse

Huberman Lab Podcast Recap

Published:

Duration: 2 hr 38 min

Guests: Dr. John Kruse

Summary

Dr. John Kruse, a psychiatrist specializing in ADHD, joins the podcast to discuss the complexities of ADHD treatment, including medications, behavioral strategies, and the impact of circadian rhythms. This episode highlights the importance of regular sleep patterns and the multifaceted nature of...

What Happened

Dr. John Kruse, an expert in ADHD treatment, emphasizes that ADHD is a disorder affecting executive functions such as working memory, selective attention, and impulse control. He notes a heritability factor of 0.8, making it as inheritable as height and schizophrenia.

The episode explores the role of stimulant medications like Adderall, Ritalin, and Vyvanse in managing ADHD symptoms. Kruse explains that while these medications can be effective, they are not a complete solution, and behavioral tools like regular sleep scheduling are crucial.

Kruse highlights how COVID-19 has increased ADHD diagnoses and stimulant prescriptions, attributing this to the decreased structure in daily life and increased demands. The pandemic's environment has also exacerbated ADHD symptoms due to more distractions in home settings.

The discussion covers the impact of circadian rhythms on ADHD, with Kruse suggesting misregulated rhythms may contribute to focus deficits. He advocates for consistent sleep patterns to improve sleep quality, especially for people with ADHD who often have a night owl chronotype.

Kruse addresses the stigma surrounding ADHD, noting it's often misunderstood due to the lack of a pathognomonic symptom. He explains that ADHD can lead to significant life challenges, including disrupted education, social relationships, and earning potential.

The potential side effects and risks of ADHD medications are discussed, including cardiovascular issues and amphetamine-induced psychosis. Kruse notes that while the risk is generally low, genetic factors can increase susceptibility in certain individuals.

Alternative treatment options like Modafinil and Wellbutrin are explored for their potential benefits in improving attention and sleep quality. Kruse also mentions lifestyle interventions such as exercise and diet, which can play a supportive role in managing ADHD.

The importance of emotional regulation in ADHD, which affects about 60% of individuals with the condition, is highlighted. However, this issue is not included in the official diagnostic criteria, emphasizing the need for a more comprehensive understanding of ADHD symptoms.

Key Insights

View all Huberman Lab recaps